As part of MAP BioPharma’s expansion into Ireland, we were delighted to announce back in October 2019 that Santé Strategy had agreed to become a part of the MAP group of market access companies.
Santé Strategy, which provides consultancy services in the Irish Healthcare sector focusing on strategic planning, market access and stakeholder engagement, will be a valuable addition to the MAP group of market access companies.
Brian Gavin, who formed Santé Strategy following a distinguished career in the BioPharma industry that included senior management roles at GSK, has been appointed Managing Director of MAP BioPharma Ireland.
Announcing the acquisition, MAP BioPharma CEO Christian Hill said “The addition of Brian’s company to MAP supports our vision to be the market leader in accelerating patient access to medicines, devices and diagnostics. Santé Strategy has helped over 40 companies to accelerate access to treatment and we are excited to enhance MAP’s presence in Ireland”.
Brian Gavin commented “We are proud to be joining the MAP group, enabling Santé Strategy to offer its clients a broader base of products and services thereby helping them to achieve their goals more than was previously possible”.
Brian has over thirty years’ experience in the healthcare sector across a range of senior management positions both in Ireland and internationally. Most of his industry experience was with GlaxoSmithKline where he held a number of senior management positions including Global Commercial Strategy Manager for Seretide, Commercial Director for GSK Ireland and subsequently Corporate Affairs Director with the company. Since 2009, Brian has provided consultancy services to a broad range of pharmaceutical companies including Abbott, Almirall, Astra Zeneca, Bayer, Biogen, Indivior, Pfizer, Mundipharma and Takeda. He has extensive experience in the submission of HTA’s to the National Centre for Pharmacoeconomics and has completed desk and field based research across a broad range of therapy areas. Developed over a number of years Brian has a comprehensive network of contacts across a broad spectrum of stakeholders in the Irish healthcare environment.
As part of the expansion into Ireland MAP BioPharma have hired their first employee in Ireland, Declan Kinahan as Market Access Manager for the Irish office.
Declan is a health economist with broad experience in both consultancy and industry environment. He graduated from National University of Ireland Galway (NUIG) with a B Comm in Economics and furthered his studies with a MSc in Health Economics from University College Cork (UCC). Declan has worked on wide-ranging projects including the development of HTA submissions and strategies in close collaboration with internal cross functional teams and external stakeholders including, NCPE, NICE, SMC; managing HTA processes and direct communication with HTA bodies and associated stakeholders; building business relationships with customers to promote regional awareness of company’s value proposition. Key attributes and skills Declan brings to the team include HTA experience, project management, client engagement, pricing and reimbursement, and value demonstration.
MAP BioPharma has a track record in successfully delivering projects across all market access relevant elements, including:
• Market access strategy
• Stakeholder mapping and engagement
• Health economic modelling
• Pricing and research strategies
With over 150 HTA submissions done in the UK and Ireland and a 89% success rate for NCPE submissions that we have made, we are excited and eager to share our considerable experience and support clients through the market access process in Ireland. Over the past six months since establishing our Ireland office we have reached out to numerous local businesses and pharmaceutical companies selling our vision to accelerate patient access to medicines, devices and diagnostics in Ireland. We have already acquired new members for our MAP Online portal along with establishing new relationships with consulting customers with signed contracts in place.
If you have an interest in the Irish market please do contact Brian or Declan. Alternatively please contact us at email@example.com
Copyright © 2020. MAP BioPharma Limited. All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
+44 (0) 1480 832360
MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281
VAT Group Registration Number GB 292 8576 52